Libmeldy 2-10 x 10^6 cells/mL dispersion for infusion
205756
Phase 3 small_molecule active
Quick answer
Libmeldy 2-10 x 10^6 cells/mL dispersion for infusion for Metachromatic Leukodystrophy (MLD) is a Phase 3 program (small_molecule) at Orchard Therapeutics (Netherlands) B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Orchard Therapeutics (Netherlands) B.V.
- Indication
- Metachromatic Leukodystrophy (MLD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active